Update on Safety Profile of Cladribine Tablets Yields Positive Results
The post-approval safety profile of cladribine tablets in relapsing MS was updated, with results consistent with development program findings and prior updates. The post-approval safety profile of...
View ArticleOfatumumab: Good Initial Adherence & Treatment Satisfaction
Participants in the novel EAFToS study had high adherence rates to initiation and maintenance doses of ofatumumab in the first interim analysis. The novel EAFToS study describes the onboarding...
View ArticleBetter Workflows Bolster LVAD Care & Cardiac Rehab Referrals
Research presented at ACC.25 focused on coordination teams and new hospital workflows designed to improve referrals and care quality for cardiology patients. Improved care coordination for patients...
View ArticleMS Activity Remains Low on Long-Term Fenebrutinib
Participants receiving the potent and highly selective BTK inhibitor fenebrutinib maintained low disease activity in the OLE of the FENopta study. Participants receiving the potent and highly selective...
View ArticleParamagnetic Rim Lesions Predict Effectiveness of Tolebrutinib
Results of a post hoc analysis of 3 phase 3 trials of tolebrutinib suggest that PRLs are associated with an increased risk for disability accumulation in MS. Results of a post hoc analysis of 3 phase 3...
View ArticleImmunomodulatory Potential of Ketogenic Diet in MS Confirmed
Researchers found that following a ketogenic diet for 6 months can reprogram immune cell metabolism and promote anti-inflammatory phenotypes in patients with MS. A new study demonstrated that a...
View ArticlePre-Relapse Immune Signature Implicates EBV Reactivation in MS Relapse
Researchers identified a monocyte/dendritic cell response to EBV reactivation in B cells as one of the earliest events in developing MS relapse. A Boston-based group of scientists found a...
View ArticleComorbidity Burden Tied to Risk for Adverse Events in MS
A higher comorbidity burden was associated with an increased rate of AESI and early discontinuation among patients with MS in clinical trials of DMTs. New study findings highlight the important role of...
View ArticleClik here to view.
Kansas and Ohio Report Surge in Measles Cases Amid Outbreaks
THURSDAY, March 27, 2025 (HealthDay News) — A measles outbreak in Kansas has rapidly escalated, doubling to 23 cases in less than a week, and health officials in Ohio report that a single case in...
View ArticleClik here to view.
ACC: Screening Mammograms + AI May ID Cardiovascular Disease
THURSDAY, March 27, 2025 (HealthDay News) — Automated deep learning-based quantification of breast arterial calcification (BAC) on routine screening mammograms may allow for opportunistic screening for...
View ArticleClik here to view.
ACC: Colorectal Cancer Tied to Higher Risk for Cardiovascular Death
THURSDAY, March 27, 2025 (HealthDay News) — Colorectal cancer (CRC) is tied to an increased risk for cardiovascular mortality, especially in individuals younger than 50 years, according to a study...
View ArticleClik here to view.
Funding Reductions Could Reverse Progress in HIV Response
THURSDAY, March 27, 2025 (HealthDay News) — Funding reductions could reverse progress in the HIV response by 2030, with the greatest effects anticipated in countries with a higher percentage of...
View ArticleClik here to view.
Sensorized T-Shirt Enables Early Discharge After Oncological Urology Surgery
THURSDAY, March 27, 2025 (HealthDay News) — A wearable T-shirt monitor can help oncological urology patients return home sooner after robotic-assisted surgery, according to a study presented at the...
View ArticleClik here to view.
Longer PSA Monitoring in Patients With Persistent PSA May Reduce Overtreatment
THURSDAY, March 27, 2025 (HealthDay News) — Assessment of prostate-specific antigen (PSA) level for three months after radical prostatectomy (RP) for prostate cancer may minimize overtreatment,...
View ArticleClik here to view.
Study Looks at Recovery Potential in Comatose Patients Who Died After Halting...
THURSDAY, March 27, 2025 (HealthDay News) — Most comatose patients resuscitated from cardiac arrest who died after withdrawal of life-sustaining therapy (WLST) were considered by experts to have...
View ArticleClik here to view.
Pelabresib Plus Ruxolitinib Improves Underlying Myelofibrosis
THURSDAY, March 27, 2025 (HealthDay News) — Pelabresib, a bromodomain and extraterminal domain inhibitor, plus ruxolitinib (a Janus kinase [JAK] inhibitor) improves signs of underlying myelofibrosis in...
View ArticleClik here to view.
Use of Parallel Transmit 7T MRI Changes Management for Epilepsy Surgery
THURSDAY, March 27, 2025 (HealthDay News) — Parallel transmit (pTx) 7 Tesla (T) magnetic resonance imaging (MRI) changes management in more than half of adult candidates for epilepsy surgery, according...
View ArticleClik here to view.
NIH Ends Funding for the Effects of Climate Change on Health
THURSDAY, March 27, 2025 (HealthDay News) — The National Institutes of Health (NIH) will no longer fund new research on how climate change affects people’s health, according to records reviewed by...
View ArticleClik here to view.
Five Top CDC Leaders Step Down Amid Wave of Departures
THURSDAY, March 27, 2025 (HealthDay News) — The U.S. Centers for Disease Control and Prevention (CDC) is facing major changes, with five senior leaders stepping down Tuesday. These exits follow three...
View ArticleClik here to view.
Chinese Woman Is Third Person to Get a Gene-Edited Pig Kidney
THURSDAY, March 27, 2025 (HealthDay News) — A Chinese woman is the third person in the world living with a gene-edited pig kidney, and nearly three weeks after surgery, doctors say she’s doing well....
View Article